Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs

Alexis M Roth; Tyler S Bartholomew; Kathleen M Ward; Allison Groves; Silvana Mazzella; Scarlett Bellamy; K Rivet Amico; Adam W Carrico; Gail Ironson; Douglas Krakower

doi:10.1093/cid/ciae450

Back

Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs

Journal article

Open access

Peer reviewed

Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs

Alexis M Roth, Tyler S Bartholomew, Kathleen M Ward, Allison Groves, Silvana Mazzella, Scarlett Bellamy, K Rivet Amico, Adam W Carrico, Gail Ironson and Douglas Krakower

Clinical infectious diseases, v 80(3), pp 621-625

15 Mar 2025

DOI: https://doi.org/10.1093/cid/ciae450

PMID: 39347705

Featured in Collection : UN Sustainable Development Goals @ Drexel

Files and links (1)

url

https://doi.org/10.1093/cid/ciae450View

CC BY V4.0, Open

Abstract

pre-exposure prophylaxis

long-acting injectable cabotegravir

women who inject drugs

HIV Prevention

Fifty-five of 62 women who inject drugs (WWID) selected long-acting cabotegravir (CAB-LA) over oral PrEP, and 51/55 received a first injection. More recent injection drug use and number of sexual partners were associated with selecting CAB-LA (P < .05). Findings provide preliminary evidence of a strong preference for longer-acting products among WWID.

Metrics

14 Record Views

4 citations in Web of Science

Details

Title: Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs
Creators: Alexis M Roth (Corresponding Author) - Drexel University
Tyler S Bartholomew - University of Miami
Kathleen M Ward - Drexel University
Allison Groves - Drexel University
Silvana Mazzella - Prevention Point Philadelphia, Philadelphia, Pennsylvania, USA
Scarlett Bellamy - Boston University
K Rivet Amico - University of Michigan
Adam W Carrico - Florida International University
Gail Ironson - University of Miami
Douglas Krakower - Harvard University
Publication Details: Clinical infectious diseases, v 80(3), pp 621-625
Publisher: Oxford University Press; CARY
Number of pages: 5
Grants: Efficacy of a Trauma Intervention for Affect Regulation, Adherence, and Substance Use to Optimize PrEP for Women Who Inject Drugs, 1R01DA054543-01, National Institutes of Health (United States, Bethesda) - NIH
Grant note: Research staff on TIARAS: Kerry Miley, Kathleen Ward, Erin McDowell, Tamica Matos, Katie Singley, Sneha Kamarajugadda, Imani Ali, Julianna Berardi, Sidney Palmer, Ally D’Angelo, Fahamida Khanam, Elana Forman, Andrea McCord, Danielle Whyte, Gabriella Ryan. PrEP staff at PPP: Kareem Mims, Desmond Doyley, Alfonso Melendez, Joy Parker, Rafael Jimenez, Silvana Mazella, Andres Friere, Anne Kelly, Jessica Misner, Daniel Smith, Kristi Petrillo, and José Benitez. This work was supported by National Institutes of Health (grant number R01DA054543; to A. M. R.) and ViiV Healthcare (A. M. R.).
Resource Type: Journal article
Language: English
Academic Unit: Epidemiology and Biostatistics; Community Health and Prevention
Web of Science ID: WOS:001325120900001
Scopus ID: 2-s2.0-105000281780
Other Identifier: 991021905414804721

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Immunology; Infectious Diseases; Microbiology

Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs

Files and links (1)

Abstract

Metrics

Details

UN Sustainable Development Goals (SDGs)

InCites Highlights

Drexel University Social media